West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 332.77 USD 0.97% Market Closed
Market Cap: 24.1B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

Net Margin
West Pharmaceutical Services Inc

17.4%
Current
21%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.4%
=
Net Income
499.6m
/
Revenue
2.9B

Net Margin Across Competitors

Country US
Market Cap 24B USD
Net Margin
17%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 202.3B USD
Net Margin
14%
Country US
Market Cap 166.6B USD
Net Margin
18%
Country KR
Market Cap 66.8T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
20%
Country US
Market Cap 36.2B USD
Net Margin
9%
Country US
Market Cap 27B USD
Net Margin
21%
Country CN
Market Cap 164.4B CNY
Net Margin
21%
Country US
Market Cap 22.2B USD
Net Margin
21%
No Stocks Found

West Pharmaceutical Services Inc
Glance View

Market Cap
24.1B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Nestled in the heart of the pharmaceutical and healthcare industry is West Pharmaceutical Services Inc., a company that has woven itself into the fabric of drug delivery systems since its founding in 1923. This company, headquartered in Exton, Pennsylvania, operates with the precision of a Swiss watch, designing and manufacturing an array of cutting-edge containment and delivery solutions for injectable medicines. West's expertise is reflected in the products it develops—ranging from stoppers and seals for vials to advanced syringe and device technologies. Its robust research and development pipeline underscores a commitment to innovation, ensuring that new advances in drug delivery provide critical safety and efficacy for patients and healthcare professionals alike. West Pharmaceutical's business model revolves around partnering closely with pharmaceutical and biotechnology companies worldwide. This symbiotic relationship secures West's place at the forefront of global healthcare evolution. While the client companies focus on the complex process of drug formulation and therapeutic efficacy, West ensures that these drugs are delivered effectively and safely through its meticulously engineered components and systems. As a result, the company garners a revenue stream from a robust portfolio of products and services that cater to the long-term needs of its clients, helping them efficiently navigate the stringent regulatory environment. Through these partnerships and their resultant dividends, West Pharmaceutical Services continues to embed its name into the essential infrastructure of global health care.

WST Intrinsic Value
223.21 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.4%
=
Net Income
499.6m
/
Revenue
2.9B
What is the Net Margin of West Pharmaceutical Services Inc?

Based on West Pharmaceutical Services Inc's most recent financial statements, the company has Net Margin of 17.4%.